<MedlineCitation Status="Completed">
<MedlineID>10011461</MedlineID>
<PMID>570424</PMID>
<DateCreated>
<Year>1979</Year>
<Month>05</Month>
<Day>26</Day>
</DateCreated>
<DateCompleted>
<Year>1979</Year>
<Month>05</Month>
<Day>26</Day>
</DateCompleted>
<DateRevised>
<Year>2000</Year>
<Month>12</Month>
<Day>18</Day>
</DateRevised>
<Article>
<Journal>
<ISSN>0006-3002</ISSN>
<JournalIssue>
<Volume>566</Volume>
<Issue>2</Issue>
<PubDate>
<Year>1979</Year>
<Month>Feb</Month>
<Day>9</Day>
</PubDate>
</JournalIssue>
</Journal>
<ArticleTitle>Active enzyme sedimentation of pig heart fumarase.</ArticleTitle>
<Pagination>
<MedlinePgn>397-9</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Active band sedimentation studies of pig heart fumarase indicate that the enzyme is predominantly tetrameric at enzyme concentrations between 0.0125 and 0.25 mg/ml and at a fumarate concentration of 2.5 mM. At enzyme concentrations of 0.25--1.0 mg/ml and fumarate concentrations known to activate and inhibit the enzyme, the sedimentation band of fumarase becomes disperse and indicates the presence of polymers greater than tetramers.</AbstractText>
</Abstract>
<AuthorList>
<Author>
<LastName>Ireland</LastName>
<ForeName>C R</ForeName>
<Initials>CR</Initials>
</Author>
<Author>
<LastName>Wolfe</LastName>
<ForeName>R G</ForeName>
<Initials>RG</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>NETHERLANDS</Country>
<MedlineTA>Biochim Biophys Acta</MedlineTA>
<NlmUniqueID>0217513</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Fumarates</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Macromolecular Systems</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 4.2.1.2</RegistryNumber>
<NameOfSubstance>Fumarate Hydratase</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName>Animal</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Enzyme Activation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Fumarate Hydratase</DescriptorName>
<QualifierName>antagonists &#38; inhibitors</QualifierName>
<QualifierName>isolation &#38; purification</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Fumarates</DescriptorName>
<QualifierName>pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Macromolecular Systems</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Myocardium</DescriptorName>
<QualifierName MajorTopicYN="Y">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Support, U.S. Gov't, P.H.S.</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Swine</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Ultracentrifugation</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
